These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 13832220)

  • 1. New live vaccines against virus diseases.
    SMORODINTSEV AA
    Am J Public Health Nations Health; 1960 Jun; 50(6)Pt 2(6 Pt 2):40-5. PubMed ID: 13832220
    [No Abstract]   [Full Text] [Related]  

  • 2. The use of beta-propiolactone for the preparation of virus vaccines. I. Selection of reaction conditions.
    POLLEY JR; GUERIN MM
    Can J Microbiol; 1957 Oct; 3(6):863-70. PubMed ID: 13472511
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccinology and selected virus diseases.
    Dull HB
    Adv Intern Med; 1971; 17():143-70. PubMed ID: 4950244
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccination against poliomyelitis with live virus vaccines. III. The evaluation to TN and SM virus vaccines.
    DANE DS; DICK GW
    Br Med J; 1957 Jan; 1(5010):70-4. PubMed ID: 13383195
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative characteristics of live vaccine against poliomyelitis prepared in the Institute of Poliomyelitis Research of the AMN SSSR, and Sabin's vaccine from attenuated strains of the poliomyelitis virus].
    CHUMAKOV MP; GAGARINA AV; LASHKEVICH VA; DZAGUROZ SG; RAL'F NM; FLEER GP; VOROSHILOVA MK; ROBINZON Ia
    Vopr Virusol; 1959; 4():533-7. PubMed ID: 13810206
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccination against poliomyelitis with live virus vaccines. I. A trial of TN type II vaccine.
    CONNOLLY JH; DANE DS; DICK GW; FISHER OD; MCKEOWN F
    Br Med J; 1957 Jan; 1(5010):59-65. PubMed ID: 13383193
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination against poliomyelitis with live virus vaccines. II. A trial of SM type I attenuated poliomyelitis virus vaccine.
    CONNOLLY JH; DANE DS; DICK GW; FISHER OD; MCKEOWN F
    Br Med J; 1957 Jan; 1(5010):65-70. PubMed ID: 13383194
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the epidemiological effectiveness of live anti-influenza vaccines of types A2 and A, A1, B].
    BERLIANT ML
    Vopr Virusol; 1960; 5():50-2. PubMed ID: 13799540
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of next-generation respiratory virus vaccines through targeted modifications to viral immunomodulatory genes.
    Stobart CC; Moore ML
    Expert Rev Vaccines; 2015; 14(12):1563-72. PubMed ID: 26434947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Live vaccines against poliomyelitis. Current status of the question].
    FERREIRA FA
    Port Med; 1960 Feb; 44():75-96. PubMed ID: 13822457
    [No Abstract]   [Full Text] [Related]  

  • 11. The removal of nonspecific components from the soluble antigens of influenza and mumps viruses.
    POLLEY JR
    Can J Microbiol; 1957 Aug; 3(5):715-9. PubMed ID: 13460819
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccination in Poland with a live attenuated vaccine against poliomyelitis].
    PRZESMYCKI F; DOBROWOLSKA H; OLAKOWSKI T; STANCZYK R; NARUSZEWICZ D
    Med Dosw Mikrobiol; 1960; 12():1-14. PubMed ID: 14435187
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutralization and heamagglutination-inhibition tests in a live influenza vaccine trial.
    BEARE AS
    Mon Bull Minist Health Public Health Lab Serv; 1962 Aug; 21():167-72. PubMed ID: 13866161
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duration of immunity in subjects vaccinated with live anti-influenza vaccine].
    GUSTYREV VF
    Vopr Virusol; 1959; 4(2):157-61. PubMed ID: 13659961
    [No Abstract]   [Full Text] [Related]  

  • 15. Sero-immune patterns for poliomyelitis and mumps in children of nomad Lapps.
    MELLBIN T
    Acta Paediatr (Stockh); 1962 Jan; 51():33-40. PubMed ID: 14472381
    [No Abstract]   [Full Text] [Related]  

  • 16. Vaccination against poliomyelitis; the current status of inactivated and attenuated virus vaccines.
    WENNER HA
    Pediatrics; 1956 Feb; 17(2):287-96. PubMed ID: 13289221
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination against poliomyelitis with live virus vaccines. 4. A review of the present position.
    DICK GW; DANE DS
    Br Med J; 1958 Nov; 2(5106):1184-6. PubMed ID: 13584892
    [No Abstract]   [Full Text] [Related]  

  • 18. Present position of immunization against poliomyelitis with live virus vaccines.
    SABIN AB
    Br Med J; 1959 Mar; 1(5123):663-80. PubMed ID: 13629086
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination against poliomyelitis with live virus vaccines. 6. Changes in Sabin type II oral vaccine virus after human passage.
    DANE DS; DICK GW; BRIGGS M; NELSON R; McALISTER J; CONNOLLY JH; HAIRE M; McKEOWN F; FIELD CM
    Br Med J; 1961 Jul; 2(5247):259-65. PubMed ID: 13719566
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccination against poliomyelitis with live virus vaccines. 7. Effect of previous Salk vaccination on virus excretion.
    DICK GW; DANE DS; McALISTER J; BRIGGS M; NELSON R; FIELD CM
    Br Med J; 1961 Jul; 2(5247):266-9. PubMed ID: 13722671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.